Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

59.28 -1.91 (-3.12%)
Streaming Delayed Price Updated: 3:28 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,148,216
Open 61.25
Bid (Size) 59.26 (1)
Ask (Size) 59.40 (1)
Prev. Close 61.19
Today's Range 57.80 - 61.75
52wk Range 30.04 - 71.13
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About CRISPR Therapeutics?
 
Via Benzinga
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%
These companies are reaching key milestones. 
Via The Motley Fool

Performance

YTD
+43.1%
+43.1%
1 Month
+2.9%
+2.9%
3 Month
+37.3%
+37.3%
6 Month
+44.7%
+44.7%
1 Year
+24.2%
+24.2%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
1 Reason Every Investor Should Know About CRISPR Therapeutics (CRSP)
Via The Motley Fool
Peering Into CRISPR Therapeutics's Recent Short Interest
Via Benzinga
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Cathie Wood's ARKK Is Beating Big Tech Like It's 2020 Again — But With A Twist
Via Benzinga
Topics Artificial Intelligence ETFs
Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns
Via The Motley Fool
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade
Via Benzinga
Topics ETFs
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
Via Benzinga
Up 50% in 3 Months, Is This Stock Still a Buy?
Via The Motley Fool
The 3 Things That Matter for CRISPR Therapeutics Now
Via The Motley Fool
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
Via Benzinga
Cathie Wood Doesn't Need Tesla To Win—ARKK Delivers A Blowout While EV Giant Idles
Via Benzinga
Topics ETFs
3 Monster Stocks in the Making to Buy Right Now
Via The Motley Fool
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
3 Monster Stocks to Hold for the Next 10 Years
Via The Motley Fool
CRISPR Stock Surges in Recent Weeks: What's Going On?
Via Benzinga
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Via Investor Brand Network
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Via FinancialNewsMedia
Topics Death
10 Monster Stocks to Hold for the Next 10 Years
Via The Motley Fool
Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch
Via Benzinga
Topics ETFs
2 Beaten-Down Stocks With Massive Upside Potential
Via The Motley Fool
2 Growth Stocks to Buy Hand Over Fist in July
Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 59.28
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 09/17/25 03:28 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.68B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.